CGAS and neoplasm: Currently, the cGAS-STING pathway has demonstrated great potential in overcoming drug resistance and enhancing anti-tumor immunity, which can be activated by STING agonists or drugs related to the activation pathway, thus playing an important role in immunotherapy.